Enstilar最新公布价格表

Enstilar is a topical treatment for plaque psoriasis that combines the active ingredients calcipotriol and betamethasone dipropionate. Its unique foam formulation is easy to use and has been approved for marketing in many countries. This article will introduce the relevant information of Enstilar in detail from three aspects: price, medication preparation and contraindications, to help patients and medical practitioners better understand this drug.

The latest announced price of Enstilar

As an imported drug, Enstilar’s ​​price and supply are the focus of patients’ attention. Below are detailed information about Enstilar prices and purchase channels.

Manufacturer and specifications

Enstilar is produced by LEO Pharma in Norway, and the specification is 2 bottles*60g/box. This packaging design facilitates long-term use by patients while ensuring the stability of drug storage.

Price information

According to the latest price list, Enstilar sells for approximately US$184 per box. Since the drug is not yet available in China, patients need to purchase it through overseas channels, and the actual price may fluctuate due to exchange rates and transportation costs.

Medical insurance and generic drugs

As of June 2025, Enstilar has not yet entered China’s medical insurance catalog, and there are no generic drugs on the market. Patients need to purchase it at their own expense or consult their doctor for other alternative treatment options.

Understanding the price information of Enstilar can help patients plan their treatment budget in advance and provide doctors with more comprehensive medication recommendations.

Enstilar medication preparation

The following are detailed instructions on medication preparation and operation steps.

Dosage form and properties

Enstilar is a foam spray, containing 50mcg calcipotriol and 0.643mg betamethasone dipropionate per gram. It is a white to off-white opalescent liquid in a pressurized aluminum spray can with a continuous valve and actuator.

How to use

Shake the jar well before use and apply the foam evenly to the affected area once a day for 4 weeks. The dosage should not be too much each time, and the maximum dosage should not exceed 60 grams every 4 days. After use, lather gently and wash hands thoroughly.

Notes

Enstilar is flammable and should be kept away from fire sources and high temperature environments when used. The medicine may cause skin irritation or allergic reaction. If discomfort occurs, stop using it immediately and consult a doctor.

Following the correct medication steps and precautions can effectively improve the therapeutic effect of Enstilar while reducing the occurrence of adverse reactions.

Contraindications of Enstilar

Understanding the contraindications of Enstilar is a prerequisite for medication. The following are details about contraindications and medication for special groups.

Contraindicated groups

Enstilar is contraindicated in patients allergic to calcipotriol or betamethasone dipropionate. In addition, use should be avoided in patients with hypercalcemia or severe hepatic and renal insufficiency.

Usage for special groups

Pregnant women, lactating women and children under 12 years old should use it with caution under the guidance of a doctor. Although there are no clear contraindications for elderly patients, due to declining body functions, close monitoring is required during medication.

Potential Risks

Long-term use of Enstilar may cause endocrine system abnormalities, such as Cushing's syndrome or hyperglycemia. Eye contact with drugs may cause cataracts or glaucoma, so avoid contact with the eyes.

Clear contraindications and potential risks can help patients and doctors use Enstilar more safely and avoid unnecessary health damage.